潘配强, 于芬芬, 单文红, 季文萱, 孙艳, 刘桂美, 黄俊彦. 羟基酪醇对对比剂诱导的肾损伤的保护作用[J]. 临床肾脏病杂志, 2019, 19(12): 917-921. DOI: 10.3969/j.issn.1671-2390.2019.12.011
    引用本文: 潘配强, 于芬芬, 单文红, 季文萱, 孙艳, 刘桂美, 黄俊彦. 羟基酪醇对对比剂诱导的肾损伤的保护作用[J]. 临床肾脏病杂志, 2019, 19(12): 917-921. DOI: 10.3969/j.issn.1671-2390.2019.12.011
    PAN Pei-qiang, YU Fen-fen, SHAN Wen-hong, JI Wen-xuan, SUN Yan, LIU Gui-mei, HUANG Jun-yan. Protective effects of hydroxytyrosol on contrast-induced nephropathy in rats[J]. Journal of Clinical Nephrology, 2019, 19(12): 917-921. DOI: 10.3969/j.issn.1671-2390.2019.12.011
    Citation: PAN Pei-qiang, YU Fen-fen, SHAN Wen-hong, JI Wen-xuan, SUN Yan, LIU Gui-mei, HUANG Jun-yan. Protective effects of hydroxytyrosol on contrast-induced nephropathy in rats[J]. Journal of Clinical Nephrology, 2019, 19(12): 917-921. DOI: 10.3969/j.issn.1671-2390.2019.12.011

    羟基酪醇对对比剂诱导的肾损伤的保护作用

    Protective effects of hydroxytyrosol on contrast-induced nephropathy in rats

    • 摘要: 目的 探讨氧化应激与对比剂肾病(contrast-induced nephropathy,CIN)的关系,及羟基酪醇对CIN大鼠的干预效果。方法 将84只大鼠随机分为3组:假手术组、模型组以及羟基酪醇干预组。对模型组和羟基酪醇干预组大鼠制备CIN模型:于大鼠尾静脉埋置留置针一枚,每隔15 min先后由鼠尾静脉注射吲哚美辛(10 mg/kg)、L-NAME(N-硝基-L-精氨酸甲酯)(10 mg/kg)和76%泛影葡胺(10 mg/kg);假手术组采用同样方法注射等量的吲哚美辛、L-NAME及生理盐水。羟基酪醇干预组于造模前3 d及被处死日当天给予羟基酪醇(10 mg·kg-1·d-1)灌胃,假手术组及模型组给予等量的生理盐水灌胃。于造模后48 h处死大鼠,观察各组大鼠血肌酐(Scr)、尿素氮(BUN)、肾脏病理改变,并采用TUNEL法检测肾细胞凋亡情况,采用ELISA法检测血清中丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)的含量。结果 假手术组无明显病理变化及细胞凋亡。与假手术组相比,模型组大鼠Scr、BUN、MDA表达明显升高,SOD及GSH-Px表达明显降低,差异均有统计学意义(P<0.05)。与模型组相比,羟基酪醇干预组Scr、BUN、MDA表达明显降低(P<0.05),SOD及GSH-Px表达明显升高(P<0.05),病理变化和细胞凋亡明显减轻,但仍重于假手术组。结论 氧化应激可能参与大鼠CIN的发生发展,而羟基酪醇可能通过减轻氧化应激反应来对对比剂诱导的大鼠肾损伤发挥保护作用。

       

      Abstract: Objective To explore the relationship between oxidative stress and contrast induced nephropathy (CIN), and observe the effects of hydroxytyrosol on CIN in CIN rats. Methods 84 Wistar rats were randomly divided into 3 groups:Sham-operation group, CIN model group and hydroxytyrosol intervention group. CIN models were prepared for rats in the CIN model group and the hydroxytyrosol intervention group:a indwelling needle was placed in the tail vein of rats; and indomethacin (10 mg/kg),L-NAME (N-nitro-L-arginine methyl ester) (10 mg/kg) and 76% panoplylamine (10 mg/kg) were injected in the same amount every 15 min; in the sham operation group, the same doses of indomethacin,L-NAME and physiological saline were injected with the same method. In the hydroxytyrosol intervention group, hydroxytyrosol (10 mg·kg-1·d-1) was administered intragastrical 3 days before and on the day of death; in the Sham-operation group and the CIN model group he same amount of saline was given intragastrical. Rats were sacrificed for collection of tissue and blood samples at 48h after modeling. Serum creatinine (Scr) and Blood urea nitrogen (BUN) were detected and pathological changes of the kidney were evaluated. Apoptosis of tubular cells was detected by TUNEL staining. The contents of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were detected by ELISA. Results No obvious pathological change and apoptosis were found in the sham-operation group. Scr, BUN and the content of MDA in the CIN model group were higher than those in the sham-operation group, the content of SOD and GSH-Px in the CIN model group were significantly lower compared with the sham-operation group (P<0.05). Scr, BUN and the content of MDA in the hydroxytyrosol intervention group were lower and the content of SOD and GSH-Px were significantly higher, compared with the CIN model group. Pathological changes and apoptosis of tubular cells in the intervention group were less serious than those in the model group, but still more serious than the sham-operation group. Conclusions Oxidative stress may be involved in pathogenesis and progression of CIN, and while hydroxytyrosol can protect CIN in rats through alleviating the oxidative stress.

       

    /

    返回文章
    返回